Prion proteins: Folding and aggregation properties;Protéines prions: Propriétés de repliement et d'agrégation

Medecine/Sciences

Volumn 21, Issue 6-7, 2005, Pages 634-640

  Bousset, Luc ^a   Melki, Ronald ^b  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

^b LABORATOIRE D ENZYMOLOGIE ET BIOCHIMIE STRUCTURALES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; POLYPEPTIDE; PRION PROTEIN;

DEGENERATIVE DISEASE; HEREDITY; INHERITANCE; PHENOTYPE; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FOLDING; REVIEW; SACCHAROMYCES CEREVISIAE;

MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 22144467370     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2005216-7634     Document Type: Review

References (36)

1. Cuille J, Chelle PL. Pathologie animale. La maladie dite tremblante du mouton est-elle inoculable? CR Acad Sci (Paris) 1936; 203: 1552-4.
2. Hadlow WJ. Scrapie and Kuru. Lancet 1959; 2: 289-90.
3. Chandler RL. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1961; 1: 1378-9.
4. Gajdusek DC. Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to β-pleated conformations. J Neuroimmunol 1988; 20: 95-110.
5. Alper T, Haig DA, Clarke MC. The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 1966; 22: 278-84.
6. Griffith JS. Self-replication and scrapie. Nature 1967; 215: 1043-4.
7. Prusiner SB, Groth DF, Cochran SP, et al. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 1980; 19: 4883-91.
8. Prusiner SB, McKinley MP, Groth DF, et al. Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci USA 1981; 78: 6675-9.
9. Prusiner SB, Bolton DC, Groth DF, et al. Further purification and characterization of scrapie prions. Biochemistry 1982; 26: 6942-50.
10. Prusiner SB, McKinley MP, Bowman KA, et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983; 35: 349-58.
11. Prusiner SB, Groth DF, Bolton DC, et al. Purification and structural studies of a major scrapie prion protein. Cell 1984; 38: 127-34.
12. Sailer A, Bueler H, Fischer M, et al. No propagation of prions in mice devoid of PrP. Cell 1994; 77: 967-8.
13. Schätzl HM, Da Costa M, Taylor L, et al. Prion protein gene variation among primates. J Mol Biol 1995; 254: 362-74.
14. Endo T, Groth D, Prusiner SB, Kobata A. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 1989; 28: 8380-8.
15. Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987; 51: 229-40.
16. Rudd PM, Endo T, Colominas C, et al. Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci USA 1999; 96: 13044-9.
17. Riek R, Hornemann S, Wider G, et al. NMR structure of the mouse prion protein domain PrP(l21-32l). Nature 1996; 382: 180-2.
18. Billeter M, Riek R, Wider G, et al. Prion protein NMR structure and species barrier for prion diseases. Proc Natl Acad Sci USA 1997; 94: 7281-5.
19. Huang Z, Prusiner SB, Cohen FE. Scrapie prions: a three-dimensional model of an infectious fragment. Folding Des 1996; 1: 13-9.
20. th ed. New York: WH Freeman and Co, 2001: 409-31.
21. Jackson GS, Hosszu LL, Power A, et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 1999; 283: 1935-7.
22. Hill AF, Antoniou M, Collinge. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 1999; 80: 11-4.
23. Legname G, Baskakov IV, Nguyen HO, et al. Synthetic mammalian prions. Science 2004; 305: 673-6.
24. Couzin J. An end to the prion debate? Don't count on it. Science 2004; 305: 589.
25. Cox BS. PSI, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 1965; 20: 505-21.
26. Lacroute F. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J Bacterial 1971; 106: 519-22.
27. Wickner RB. Evidence for a prion analog in S. cerevisiae: The [URE3] non-Mendelian genetic element as an altered URE2 protein. Science 1994; 264: 566-9.
28. Serio TR, Cashikar AG, Kowal AS, et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000; 289: 1317-21.
29. Bousset L, Thomson NH, Radford SE, Melki R. The yeast prion Ure2p retains its native alpha-helical conformation upon assembly into protein fibrils in vitro. EMBO J 2002; 21: 2903-11.
30. Sunde M, Serpell LC, Bartlam M, et al. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 1997; 273: 729-39.
31. Zurdo J, Guijarro JI, Dobson CM. Preparation and characterization of purified amyloid fibrils. J Am Chem Soc 2001; 123: 8141-2.
32. Bousset L, Briki F, Doucet J, Melki R. The native-like conformation of Ure2p in fibrils assembled under physiologically relevant conditions switches to an amyloid-like conformation upon heat-treatment of the fibrils. J Struct Biol 2003; 141: 132-42.
33. Abram D, Koffler H. In vitro formation of flagella-like filaments and other structure from flagellin. J Mol Biol 1964; 9: 168-85.
34. Lomas DA, Carrell RW. Serpinopathies and the conformational dementias. Nat Rev Genet 2002; 3: 759-68.
35. Tuite MF, Cox BS. Propagation of yeast prions. Nat Rev 2003; 4: 878-89.
36. Bousset L, Belrhali H, Janin J, et al. Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae. Structure 2001; 9: 39-46.